Prostate Supreme
Natural health product licensed in Canada
- Licence holder
- Designs for Health
- NPN or DIN-HM
- 80072821
- Status
- Active licence
- Licence date
- 30 September 2016
- Revision date
- Not provided
- Form
- Capsule
- Route of administration
- Orale
- Application type
- Non traditionnelle
If this product were sold in France
- Dose déclarée au-delà d'une limite
Vitamine B6: up to 10 mg a day according to the dosing instructions published by Health Canada (2 unités posologiques par jour au plus, pour les adultes), above the maximum dose of 2 mg set in France for a food supplement (2006 Order, not revised since November 2006).
arrêté du 9 mai 2006, annexe III. French orders of 9 May 2006 and 14 November 2006 as published in the Official Journal (maximum daily doses), retrieved 21 October 2026.
- Conditions légales
Serenoa repens (W.Bartram) Small: L'étiquetage doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
- Conditions légales
Urtica dioica L.: L'étiquetage des compléments alimentaires contenant les parties souterraines de cette plante doit comporter une mention recommandant de prendre conseil auprès d'un professionnel de santé ("Demander l'avis de votre médecin et /ou pharmacien").
arrêté du 24 juin 2014, annexe I. French orders of 9 May 2006 (nutrients), 24 June 2014 (plants) and 26 September 2016 (other substances), consolidated LEGI collection, retrieved 23 October 2026.
A daily quantity is calculated only for an explicit adult oral dosage, stated per day and in a solid unit matching the product form. Ambiguous units, liquids, powders and paediatric doses are not extrapolated. A quantity not calculated is not compared with dose limits. This analysis does not constitute authorisation for sale in France or an assessment of safety or efficacy.
Composition
| Medicinal ingredient and source | Per dosage unit, according to the source | Maximum per day, adult |
|---|---|---|
| Zinc Source : Diglycinate de zinc | 5 milligramme | 10,000 µg |
| Acide aminoacétique Source : Glycine | 50 milligramme | Not calculated |
| Vitamine D Source : Cholécalciférol Potency : 500 UI | 12.5 microgrammes | Not calculated |
| Vitamine B6 Source : Chlorhydrate de pyridoxine | 5 milligramme | 10,000 µg |
| Serenoa repens Source : Fruit Potency : 45 % Fatty acids | 225 milligramme | Not calculated |
| Urtica dioica Source : Racine Extraction ratio : 12:1 Dry plant equivalent : 1,500 milligramme Potency : 0.8 % beta-Sitosterol | 125 milligramme | Not calculated |
| L-alanine | 50 milligramme | Not calculated |
| Acide L-glutamique Source : Acide glutamique | 50 milligramme | Not calculated |
| 5,7-Dihydroxyflavone Source : Chrysine | 50 milligramme | Not calculated |
| 3,3'-diindolylméthane Source : Brassica oleracea var. italica - plante entière | 50 milligramme | Not calculated |
| Cucurbita pepo Source : Graine(s) Extraction ratio : 10:1 Dry plant equivalent : 300 milligramme | 30 milligramme | Not calculated |
| Lycopène tout trans Source : Solanum lycopersicum - Chair (fruit) | 10 milligramme | Not calculated |
Non-medicinal ingredients
Dioxyde de silicium, Stéarate de magnésium, Gélatine
Recommended doses in Canada
| Population | Age | Quantity per serving | Frequency |
|---|---|---|---|
| Adultes de sexe masculin | Not specified | 2 Capsule | 1 Tous les jours |
Uses authorised in Canada
Helps support prostate health.
A use authorised in Canada is not an authorised health claim in the European Union. See the health claims register.
Warnings in Canada
- Précautions et mises en garde
Consult a health care practitioner if symptoms persist or worsen. Consult a health care practitioner prior to use if you have or are pre-disposed to cancer to exclude a diagnosis of prostate cancer. Consult a healthcare practitioner prior to use if you have diabetes. Consult a health care practitioner prior to use if you have liver or kidney disease or if you have been instructed to follow a low protein diet. Consult a healthcare practitioner if you are taking any medications. Consult a healthcare practitioner prior to use if you have a liver disorder or develop liver-related symptoms (e.g. abdominal pain, jaundice, dark urine).
- Effets indésirables connus
May cause gastrointestinal upset; May cause diarrhoea and hyperglycemia. Discontinue use if you experience joint pain or hot flashes.
Source
Official Health Canada record, licence 80072821
Licensed Natural Health Products Database (LNHPD), Health Canada: licensed products, ingredients, doses, uses and risks, retrieved 27 October 2026.
Contains information licensed under the Open Government Licence – Canada (Health Canada, LNHPD)
Licence du gouvernement ouvert – Canada 2.0 (OGL-Canada 2.0)
The formula sold in Europe under the same name may differ. This information does not replace advice from a doctor or pharmacist.
The evidence date of this ingredient list is unknown.
Has the product changed? Photograph the packaging.